Jun 10 2011
This Malaria Policy Center blog post describes the event "Spurring health and wealth through medical breakthroughs," during which Washington Post columnist and ONE Fellow Michael Gerson; John Lusingu, principal research scientist at the Tanzania National Institute for Medical Research and co-principal investigator in the RTS,S malaria vaccine trial in Tanzania for the PATH Malaria Vaccine Initiative; and Margaret McGlynn, board member of the International AIDS Vaccine Initiative and former president of Merck Global Vaccines and Anti-Infectives, "brought unique perspectives to the impact of new vaccines on many global health issues, particularly HIV/AIDS and malaria" (Todd, 6/8).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors